drugset
drugset / Trial / NCT04130633

Behavioral Pharmacology of THC and Alpha-pinene

NCT04130633 ↗

Phase 1 Completed 33 enrolled Johns Hopkins University National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverDouble-blindBasic science

Summary

This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized alpha-pinene and THC administered via inhalation.

Timeline

Start
2020-11-05
Primary completion
2024-03-08
Completion
2024-03-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Alpha-Pinene Small molecule 0.5 mg Inhaled
Subject Alpha-Pinene Small molecule 5 mg Inhaled
Subject Alpha-Pinene Small molecule 15 mg Inhaled
Subject THC Unknown 30 mg Inhaled

Indications

No indication recorded.